Answers are grounded in this paper and cite their sources.
Observational findings connect ANK1 and EPB41 variants to increased osteonecrosis risk, suggesting novel pathways for intervention.
These findings suggest that the rare variants in ANK1 and EPB41 are novel SONFH disease risk factors which compromise erythrocyte membrane integrity, exacerbating microcirculatory damage in the presence of glucocorticoid as a second hit.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: